Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.54 |
| ▸ | LMNA | P02545 | 1/20 | 0.54 |
| ▸ | MAPK8 | P45983 | 7/20 | 0.52 |
| ▸ | MAPK10 | P53779 | 7/20 | 0.52 |
| ▸ | MAPK9 | P45984 | 6/20 | 0.52 |
| ▸ | HTT | P42858 | 2/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.50 |
| ▸ | TP53 | P04637 | 1/20 | 0.49 |
| ▸ | MEN1 | O00255 | 2/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.48 |
| ▸ | CA12 | O43570 | 1/20 | 0.47 |
| ▸ | CA1 | P00915 | 1/20 | 0.47 |
| ▸ | CA2 | P00918 | 1/20 | 0.47 |
| ▸ | CA9 | Q16790 | 1/20 | 0.47 |
| ▸ | NOD2 | Q9HC29 | 1/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1492349 | 0.87 | KMT2A (0.53) | SMN1; SMN2LMNAMAPK8MAPK10MAPK9 | |
| SCHEMBL31735479 | 0.82 | POLB (0.57) | LMNAMAPK8MAPK10MAPK9HTT | |
| SCHEMBL25241521 | 0.81 | KDM4E (0.51) | LMNAMAPK10HTTALDH1A1MEN1 | |
| SCHEMBL10293980 | 0.77 | HTT (0.52) | SMN1; SMN2LMNAMAPK8MAPK10MAPK9 | |
| SCHEMBL1492325 | 0.76 | KDM4E (0.50) | SMN1; SMN2LMNAHTTALDH1A1MEN1 | |
| SCHEMBL4200796 | 0.75 | ALDH1A1 (0.45) | SMN1; SMN2LMNAHTTALDH1A1MEN1 | |
| SCHEMBL1536623 | 0.72 | SMN1; SMN2 (0.53) | SMN1; SMN2HTTALDH1A1TP53MEN1 | |
| SCHEMBL2626729 | 0.72 | KMT2A (0.44) | SMN1; SMN2LMNAHTTALDH1A1MEN1 | |
| SCHEMBL1492249 | 0.72 | SMN1; SMN2 (0.47) | SMN1; SMN2LMNAMAPK8MAPK10MAPK9 | |
| SCHEMBL1536712 | 0.71 | MAPT (0.53) | LMNAHTTALDH1A1MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2475660-A1 | PYRROLO-PYRIDINE DERIVATIVES AS ACTIVATORS OF AMPK | GlaxoSmithKline LLC (US) | 2012-07-18 | — | — | EP | disclosed |
| US-20120172333-A1 | PYRROLO-PYRIDINE DERIVATIVES AS ACTIVATORS OF AMPK | GLAXOSMITHKLINE LLC (US) | 2012-07-05 | — | — | US | disclosed |
| WO-2011029855-A1 | PYRROLO-PYRIDINE DERIVATIVES AS ACTIVATORS OF AMPK | GLAXOSMITHKLINE LLC (US) | 2011-03-17 | — | — | WO | disclosed |
| WO-2011029855-A1 | PYRROLO-PYRIDINE DERIVATIVES AS ACTIVATORS OF AMPK | GLAXOSMITHKLINE LLC (US) | 2011-03-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120172333-A1 | PYRROLO-PYRIDINE DERIVATIVES AS ACTIVATORS OF AMPK | PRKAB1, PRKAG1, PRKAB2 | SMN1; SMN2 4359/4885LMNA 4305/4885MAPK8 458/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.